GNRH1 and cartilage-hair hypoplasia: Of interest, pharmacochaperones rescue misfolded Gnrhr in murine models, disable the ability of Gnrhr mutants to reach the plasma membrane, and restore their ability to respond to endogenous Gnrh ligand, thus being a promising strategy to treat CHH patients with a genetic profile similar to the affected individuals in Family A [34].